Cue Biopharma Inc (NASDAQ:CUE)

Delayed Data
As of 4:00pm ET
 +0.16 / +1.81%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Cue Biopharma Inc have a median target of 30.00, with a high estimate of 32.00 and a low estimate of 20.00. The median estimate represents a +233.33% increase from the last price of 9.00.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Cue Biopharma Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 16

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 10.16%
Growthannually 6.69%


Growthquarterly 23.84%
Growthannually 192.29%
Key to the earnings and sales forecast charts.